Developing tools to understand immune responses in HIV/AIDS.
NIH TETRAMER CORE FACILITY (HIV/AIDS)
This study is all about helping scientists learn more about how our immune system fights HIV/AIDS by providing them with special tools, which could lead to better vaccines and treatments for patients like you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Emory University NIH-funded |
| Lab location | 1 site (Atlanta, United States) |
| Project ID | NIH-10589009 on NIH RePORTER |
What this research studies
This research focuses on enhancing our understanding of immune responses related to HIV/AIDS by providing essential resources such as MHC tetramer reagents. These reagents are synthesized and distributed to researchers worldwide, enabling them to study how the immune system recognizes and responds to HIV. By improving the tools available for biomedical research, the project aims to facilitate the development of effective vaccines and therapies for HIV/AIDS and other infectious diseases. Patients may benefit indirectly through advancements in treatment options that arise from this research.
Who could benefit from this research
Good fit: Ideal candidates for benefiting from this research include individuals living with HIV/AIDS and those at risk of infection.
Not a fit: Patients with conditions unrelated to HIV/AIDS or those not engaged in research may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccines and therapies for HIV/AIDS, enhancing patient outcomes.
How similar studies have performed: Previous research utilizing MHC tetramers has shown promise in understanding immune responses, indicating that this approach is supported by successful methodologies.
Where this research is happening
Atlanta, United States
- Emory University — Atlanta, United States (Active)
Researchers
- Principal investigator: Altman, John — Emory University
- Study coordinator: Altman, John
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.